160 related articles for article (PubMed ID: 34676244)
1. Integrative Analysis of Metallothioneins Identifies MT1H as Candidate Prognostic Biomarker in Hepatocellular Carcinoma.
Zhang F; Guo S; Zhong W; Huang K; Liu Y
Front Mol Biosci; 2021; 8():672416. PubMed ID: 34676244
[No Abstract] [Full Text] [Related]
2. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
[TBL] [Abstract][Full Text] [Related]
3. Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins.
Gou R; Zhu L; Zheng M; Guo Q; Hu Y; Li X; Liu J; Lin B
J Transl Med; 2019 Sep; 17(1):275. PubMed ID: 31474227
[TBL] [Abstract][Full Text] [Related]
4. Trace Elements Status and Metallothioneins DNA Methylation Influence Human Hepatocellular Carcinoma Survival Rate.
Udali S; De Santis D; Mazzi F; Moruzzi S; Ruzzenente A; Castagna A; Pattini P; Beschin G; Franceschi A; Guglielmi A; Martinelli N; Pizzolo F; Ambrosani F; Olivieri O; Choi SW; Friso S
Front Oncol; 2020; 10():596040. PubMed ID: 33585212
[TBL] [Abstract][Full Text] [Related]
5. The roles of metallothioneins in carcinogenesis.
Si M; Lang J
J Hematol Oncol; 2018 Aug; 11(1):107. PubMed ID: 30139373
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of MT Family Isoforms as Potential Biomarker for Predicting Progression and Prognosis in Gastric Cancer.
Tong M; Lu W; Liu H; Wu J; Jiang M; Wang X; Hao J; Fan D
Biomed Res Int; 2019; 2019():2957821. PubMed ID: 31380415
[TBL] [Abstract][Full Text] [Related]
7. Prognostic roles of the transcriptional expression of exportins in hepatocellular carcinoma.
Chen L; Huang Y; Zhou L; Lian Y; Wang J; Chen D; Wei H; Huang M; Huang Y
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31371628
[No Abstract] [Full Text] [Related]
8. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
[TBL] [Abstract][Full Text] [Related]
9. Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma.
Huang YL; Ning G; Chen LB; Lian YF; Gu YR; Wang JL; Chen DM; Wei H; Huang YH
Cancer Manag Res; 2019; 11():1725-1740. PubMed ID: 30863181
[TBL] [Abstract][Full Text] [Related]
10. The Difference in Zinc Concentrations Required for Induction among Metallothionein Isoforms Can Be Explained by the Different MTF1 Affinities to MREs in Its Promoter.
Ogushi S; Kimura T
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613726
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
[TBL] [Abstract][Full Text] [Related]
12. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
13. Oncogene PLCE1 may be a diagnostic biomarker and prognostic biomarker by influencing cell cycle, proliferation, migration, and invasion ability in hepatocellular carcinoma cell lines.
Wang XK; Liao XW; Yang CK; Liu ZQ; Han QF; Zhou X; Zhang LB; Deng T; Gong YZ; Huang JL; Huang R; Han CY; Yu TD; Su H; Ye XP; Peng T; Zhu GZ
J Cell Physiol; 2020 Oct; 235(10):7003-7017. PubMed ID: 32037547
[TBL] [Abstract][Full Text] [Related]
14. Centromere Protein F (
Huang Y; Chen X; Wang L; Wang T; Tang X; Su X
J Cancer; 2021; 12(10):2933-2951. PubMed ID: 33854594
[TBL] [Abstract][Full Text] [Related]
15. Metallothionein Isoform Expression in Benign and Malignant Thyroid Lesions.
Wojtczak B; Pula B; Gomulkiewicz A; Olbromski M; Podhorska-Okolow M; Domoslawski P; Bolanowski M; Daroszewski J; Dziegiel P
Anticancer Res; 2017 Sep; 37(9):5179-5185. PubMed ID: 28870952
[TBL] [Abstract][Full Text] [Related]
16. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
17. Potential Role of NEU1 in Hepatocellular Carcinoma: A Study Based on Comprehensive Bioinformatical Analysis.
Wu Z; He L; Yang L; Fang X; Peng L
Front Mol Biosci; 2021; 8():651525. PubMed ID: 34513919
[No Abstract] [Full Text] [Related]
18. Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma.
Cai X; Zhou J; Deng J; Chen Z
Cancer Cell Int; 2021 Dec; 21(1):701. PubMed ID: 34937564
[TBL] [Abstract][Full Text] [Related]
19. Metallothionein 1F and 2A overexpression predicts poor outcome of non-small cell lung cancer patients.
Werynska B; Pula B; Muszczynska-Bernhard B; Gomulkiewicz A; Piotrowska A; Prus R; Podhorska-Okolow M; Jankowska R; Dziegiel P
Exp Mol Pathol; 2013 Feb; 94(1):301-8. PubMed ID: 23064051
[TBL] [Abstract][Full Text] [Related]
20.
Xie X; Jiang S; Li X
Front Oncol; 2021; 11():621373. PubMed ID: 33767990
[No Abstract] [Full Text] [Related]
[Next] [New Search]
